Corrigendum: <i>Ex vivo</i> modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes. The gene discussed is CTLA4; the disease is neoplasm.